Concepedia
Statistics
Publications
10
Citations
2.2K
H-Index
Active since
1982
Affiliations
New Frontier(Current)
Hahnemann University Hospital
GlaxoSmithKline (Netherlands)
Mary Jo Caranfa is an author at New Frontier specializing in molecular biology, life sciences, and enzyme inhibition.
Publications per year
1982–1993
On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex
Robert Hertzberg, Mary Jo Caranfa, Sidney M. Hecht · Biochemistry · 1989 · 552 citations
Medicine, Biochemistry, Pharmacology +10
Synthesis of water-soluble (aminoalkyl)camptothecin analogs: inhibition of topoisomerase I and antitumor activity
William D. Kingsbury, Jeffrey C. Boehm, Dalia R. Jakas et al. · Journal of Medicinal Chemistry · 1991 · 516 citations
Medicine, Medicinal Chemistry, Pharmacology +10
Modification of the hydroxylactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity
Robert Hertzberg, Mary Jo Caranfa, Kenneth G. Holden et al. · Journal of Medicinal Chemistry · 1989 · 414 citations
Medicine, Medicinal Chemistry, Pharmacology +12
The inophyllums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malaysian tree, Calophyllum inophyllum Linn
Ashok D. Patil, Alan J. Freyer, Drake S. Eggleston et al. · Journal of Medicinal Chemistry · 1993 · 412 citations · Full text
Life Sciences, Botany, Pharmacology +12
Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase I.
R S Gupta, Rajan Gupta, Barry Eng et al. · PubMed · 1988 · 125 citations
Medicine, Molecular Biology, Oncology +15
1–5 of 10